Skip to main content
Premium Trial:

Request an Annual Quote

Komen to Fund Cancer PGx Research through New Grants

NEW YORK (GenomeWeb News) – Susan G. Komen for the Cure, a non-profit organization dedicated to funding breast cancer research and education, has awarded $60 million in grants to US and international researchers, including nearly $19 million to fund research into pharmacogenomics.

The funding for the pharmacogenomic research is provided through the organization's Promise Grants.

Komen, along with the Triple Negative Breast Cancer Foundation, has awarded $6.4 million to the University of Alabama at Birmingham to study adding a new drug, along with chemotherapy in treating triple negative breast cancer. That research project includes looking for ways to predict which therapies will be most effective for triple negative breast cancer patients.

Indiana University will receive a $5.8 million Promise Grant to identify biomarkers to predict which breast cancer patients will benefit from the drug bevacizumab (Avastin), and which patients will suffer significant side effects from use of the drug.

Researchers at Thomas Jefferson University in Philadelphia will use a $6.7 million Promise Grant to find biomarkers to predict treatment response and match patients with the best treatment option.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.